Literature DB >> 17760884

Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS.

Evanthia Diamanti-Kandarakis1, Dimitrios Panidis.   

Abstract

BACKGROUND: The phenotypic spectrum of PCOS has been broadened but the prevalence and clinical significance of PCOS phenotypes continue to challenge the scientific community.
OBJECTIVE: Analysis of the phenotypic spectrum of PCOS and determination of the association between metabolic, hormonal and new ultrasonographic criteria.
DESIGN: Clinical prospective study. PATIENTS: Six hundred and thirty-four women with PCOS (18-35 years) and comparable body mass index (BMI), diagnosed by ESHRE/ASRM criteria, were categorized into two major groups of phenotypes: classic (NIH) and nonclassic (ESHRE/ASRM), and then subdivided into phenotypes with all possible combinations of diagnostic characteristics. One hundred and eight healthy women of reproductive age, matched for BMI, were recruited as the control group. MEASUREMENTS: Ultrasonographic (ovarian follicle number and volume), hormonal and metabolic parameters.
RESULTS: Classic PCOS phenotype was more frequent (85.96%) than the nonclassic phenotype (14.04%). The patients were also classified according to the presence of biochemical (80.60%) or clinical hyperandrogenaemia (12.62%), and, in the newly introduced group, to absence of evidence of hyperandrogenaemia (6.78%). Subjects with classic PCOS with biochemical hyperandrogenaemia (74.76%) were more insulin resistant than controls. In women with PCOS, follicle number was positively related to both insulin resistance and biochemical hyperandrogenaemia. Additionally, women with PCOS had a 6.58-fold increased relative risk (RR) of > 12 follicles on intravaginal ultrasound and a 2.94-fold increased RR of ovarian volume > 10 cm(3) compared to controls.
CONCLUSION: The most frequent PCOS phenotype is the subgroup with biochemical hyperandrogenaemia only within the classic phenotype, which is more insulin resistant than the control group. The follicle number, a newly introduced ultrasonographic marker, is related to both metabolic and hormonal features of PCOS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17760884     DOI: 10.1111/j.1365-2265.2007.02954.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  41 in total

1.  Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold?

Authors:  Evanthia Diamanti-Kandarakis
Journal:  Nat Rev Endocrinol       Date:  2012-05-01       Impact factor: 43.330

2.  Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.

Authors:  Sarantis Livadas; Christos Pappas; Athanasios Karachalios; Evangelos Marinakis; Nikoleta Tolia; Maria Drakou; Philippos Kaldrymides; Dimitrios Panidis; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2014-04-22       Impact factor: 3.633

3.  Grid analysis improves reliability in follicle counts made by ultrasonography in women with polycystic ovary syndrome.

Authors:  Marla E Lujan; Eric D Brooks; Anna L Kepley; Donna R Chizen; Roger A Pierson; Andrew K Peppin
Journal:  Ultrasound Med Biol       Date:  2010-04-09       Impact factor: 2.998

4.  Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome.

Authors:  Nina M Clark; Amanda J Podolski; Eric D Brooks; Donna R Chizen; Roger A Pierson; Denis C Lehotay; Marla E Lujan
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

5.  Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.

Authors:  Uche Ezeh; Bulent O Yildiz; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

Review 6.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

7.  Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China.

Authors:  Jia Huang; Renmin Ni; Xiaoli Chen; Lili Huang; Yaqin Mo; Dongzi Yang
Journal:  Reprod Biol Endocrinol       Date:  2010-11-17       Impact factor: 5.211

8.  Chronic combined hyperandrogenemia and western-style diet in young female rhesus macaques causes greater metabolic impairments compared to either treatment alone.

Authors:  C A True; D L Takahashi; S E Burns; E C Mishler; K R Bond; M C Wilcox; A R Calhoun; L A Bader; T A Dean; N D Ryan; O D Slayden; J L Cameron; R L Stouffer
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

9.  Combined androgen excess and Western-style diet accelerates adipose tissue dysfunction in young adult, female nonhuman primates.

Authors:  Oleg Varlamov; Cecily V Bishop; Mithila Handu; Diana Takahashi; Sathya Srinivasan; Ashley White; Charles T Roberts
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

Review 10.  Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.

Authors:  Marla E Lujan; Donna R Chizen; Roger A Pierson
Journal:  J Obstet Gynaecol Can       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.